Extended-release methylphenidate monotherapy in patients with comorbid social anxiety disorder and adult attention-deficit/hyperactivity disorder: retrospective case series
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, cilt.7, sa.11, ss.241-247, 2017 (SCI-Expanded)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 7 Sayı: 11
- Basım Tarihi: 2017
- Doi Numarası: 10.1177/2045125317714193
- Dergi Adı: THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), EMBASE, Directory of Open Access Journals
- Sayfa Sayıları: ss.241-247
- Anahtar Kelimeler: attention-deficit/hyperactivity disorder, comorbidity, extended-release methylphenidate, social anxiety disorder, treatment, DEFICIT HYPERACTIVITY DISORDER, AGE-DEPENDENT DECLINE, PSYCHIATRIC COMORBIDITY, ATOMOXETINE TREATMENT, CONTROLLED-TRIAL, ADHD, CHILDREN, PREVALENCE, PHOBIA, PREDICTORS
- İstanbul Üniversitesi Adresli: Evet
Özet
Background: The relationship between social anxiety disorder (SAD) and attention-deficit/hyperactivity disorder (ADHD) is a subject which has recently become a topic of interest for research.